Daniel A. Carestio
Net Worth

Last updated:

What is Daniel A. Carestio net worth?

The estimated net worth of Mr. Daniel A. Carestio is at least $19,292,554 as of 2 Jun 2021. He owns shares worth $6,575,869 as insider, has earned $4,076,685 from insider trading and has received compensation worth at least $8,640,000 in STERIS plc.

What is the salary of Daniel A. Carestio?

Mr. Daniel A. Carestio salary is $1,440,000 per year as Pres, Chief Executive Officer & Director in STERIS plc.

How old is Daniel A. Carestio?

Mr. Daniel A. Carestio is 52 years old, born in 1973.

What stocks does Daniel A. Carestio currently own?

As insider, Mr. Daniel A. Carestio owns shares in one company:

Company Title Shares Price per share Total value
STERIS plc (STE) Pres, Chief Executive Officer & Director 26,314 $249.9 $6,575,869

What does STERIS plc do?

STERIS plc provides infection prevention and other procedural products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier and sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The Dental segment provides hand and powered dental instruments, infection control products, personal protective equipment, and water quality products for dental suite. The company serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is based in Dublin, Ireland.

Daniel A. Carestio insider trading

STERIS plc

Mr. Daniel A. Carestio has made 7 insider trades between 2019-2021, according to the Form 4 filled with the SEC.

The largest trade he's ever made was exercising 59,316 units of STE stock on 2 Jun 2021. As of 2 Jun 2021 he still owns at least 26,314 units of STE stock.

Transaction Date Security Shares Price per share Total value Source
Option
Employee Stock Option (right to buy) 59,316 $210.3 $12,474,155
Option
Ordinary Shares 13,500 N/A N/A
Sale
Ordinary Shares 13,500 N/A N/A
Option
Employee Stock Option (right to buy) 13,500 N/A N/A
Sale
Ordinary Shares 13,500 $73.31 $989,631
Option
Ordinary Shares 15,000 N/A N/A
Option
Employee Stock Option (right to buy) 15,000 N/A N/A
Sale
Ordinary Shares 15,000 $175.77 $2,636,550
Sale
Ordinary Shares 15,000 N/A N/A
Option
Ordinary Shares 8,000 N/A N/A
Option
Employee Stock Option (right to buy) 8,000 N/A N/A
Sale
Ordinary Shares 8,000 $56.31 $450,504
Sale
Ordinary Shares 8,000 N/A N/A
Option
Employee Stock Option (right to buy) 26,776 N/A N/A
Option
Employee Stock Option (right to buy) 7,000 N/A N/A
Option
Ordinary Shares 7,000 N/A N/A
Sale
Ordinary Shares 7,000 N/A N/A

STERIS key executives

STERIS plc executives and other stock owners filed with the SEC: